Correlation Between Senti Biosciences and Acrivon Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Senti Biosciences and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Senti Biosciences and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Senti Biosciences and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Senti Biosciences and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Senti Biosciences with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Senti Biosciences and Acrivon Therapeutics,.
Diversification Opportunities for Senti Biosciences and Acrivon Therapeutics,
0.38 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Senti and Acrivon is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding Senti Biosciences and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Senti Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Senti Biosciences are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Senti Biosciences i.e., Senti Biosciences and Acrivon Therapeutics, go up and down completely randomly.
Pair Corralation between Senti Biosciences and Acrivon Therapeutics,
Given the investment horizon of 90 days Senti Biosciences is expected to under-perform the Acrivon Therapeutics,. In addition to that, Senti Biosciences is 1.31 times more volatile than Acrivon Therapeutics, Common. It trades about -0.01 of its total potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about 0.01 per unit of volatility. If you would invest 1,250 in Acrivon Therapeutics, Common on September 1, 2024 and sell it today you would lose (492.00) from holding Acrivon Therapeutics, Common or give up 39.36% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Senti Biosciences vs. Acrivon Therapeutics, Common
Performance |
| Timeline |
| Senti Biosciences |
| Acrivon Therapeutics, |
Senti Biosciences and Acrivon Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Senti Biosciences and Acrivon Therapeutics,
The main advantage of trading using opposite Senti Biosciences and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Senti Biosciences position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.| Senti Biosciences vs. Cadrenal Therapeutics, Common | Senti Biosciences vs. Foghorn Therapeutics | Senti Biosciences vs. Quoin Pharmaceuticals Ltd | Senti Biosciences vs. SAB Biotherapeutics |
| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |